---
figid: PMC9457753__molecules-27-05481-g002
figtitle: 'Lipopolysaccharide-Induced Model of Neuroinflammation: Mechanisms of Action,
  Research Application and Future Directions for Its Use'
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC9457753
filename: molecules-27-05481-g002.jpg
figlink: /pmc/articles/PMC9457753/figure/molecules-27-05481-f002/
number: F2
caption: 'Mechanisms of molecular response to LPS. A detailed description can be found
  in the section ‘Cellular recognition of LPS’. Abbreviations: AP-1—activator protein-1;
  CD14—cluster of differentiation-14; CGRP—calcitonin gene-related peptide; COX-2—cyclooxygenase-2;
  GSDMD— gasdermin-D; IFN—interferon; IKK—Iκβ kinase complex; IKKi—IKK inducible kinase;
  IL—interleukin; iNOS—inducible nitric oxide synthase; IRAK—interleukin-1 receptor
  associated kinase; IRF—interferon regulatory factor; LBP—lipopolysaccharide-binding
  protein; LPS—lipopolysaccharide; MAL—MyD88—adopter-like protein; MAPK—mitogen-activated
  protein kinase; MD-2—accessory protein MD-2; MyD88—myeloid differentiation primary
  response protein; NLRP3—NLR family pyrin domain containing 3; NEMO—NF-κB essential
  modulator; NF-κB—nuclear factor-κB; NO—nitric oxide; SP—substance P; TAB—TAK1 binding
  protein; TAK1—transforming growth factor β-activated kinase 1; TBK1—TANK-binding
  kinase 1; TIR—Toll/IL-1 receptor domain; TIRAP—TIR domain containing adaptor protein;
  TNF-α—tumor necrosis factor-α; TLR4 —Toll-like receptor 4; TRAF—TNF-receptor associated
  factor; TRAM—TRIF-related adaptor molecule; TRIF—Toll/interleukin-1-receptor domain-containing
  adaptor inducing interferon β; TRPA1—transient receptor potential ankyrin 1; TRPM3—transient
  receptor potential melastatin 3; TRPM8—transient receptor potential melastatin 8;
  TRPV1—transient receptor potential cation channel subfamily V member 1; TRPV4 -
  transient receptor potential vanilloid 4. Adapted from ‘TLR Signaling Pathway’,
  by BioRender.com (2022). Retrieved from https://app.biorender.com/biorender-templates
  (accessed on 15 July 2022).'
papertitle: 'Lipopolysaccharide-Induced Model of Neuroinflammation: Mechanisms of
  Action, Research Application and Future Directions for Its Use.'
reftext: Anna Skrzypczak-Wiercioch, et al. Molecules. 2022 Sep;27(17):5481.
year: '2022'
doi: 10.3390/molecules27175481
journal_title: Molecules
journal_nlm_ta: Molecules
publisher_name: MDPI
keywords: lipopolysaccharide | neuroinflammation | neurodegenerative diseases | Alzheimer’s
  disease | Toll-like receptor 4
automl_pathway: 0.954078
figid_alias: PMC9457753__F2
figtype: Figure
redirect_from: /figures/PMC9457753__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9457753__molecules-27-05481-g002.html
  '@type': Dataset
  description: 'Mechanisms of molecular response to LPS. A detailed description can
    be found in the section ‘Cellular recognition of LPS’. Abbreviations: AP-1—activator
    protein-1; CD14—cluster of differentiation-14; CGRP—calcitonin gene-related peptide;
    COX-2—cyclooxygenase-2; GSDMD— gasdermin-D; IFN—interferon; IKK—Iκβ kinase complex;
    IKKi—IKK inducible kinase; IL—interleukin; iNOS—inducible nitric oxide synthase;
    IRAK—interleukin-1 receptor associated kinase; IRF—interferon regulatory factor;
    LBP—lipopolysaccharide-binding protein; LPS—lipopolysaccharide; MAL—MyD88—adopter-like
    protein; MAPK—mitogen-activated protein kinase; MD-2—accessory protein MD-2; MyD88—myeloid
    differentiation primary response protein; NLRP3—NLR family pyrin domain containing
    3; NEMO—NF-κB essential modulator; NF-κB—nuclear factor-κB; NO—nitric oxide; SP—substance
    P; TAB—TAK1 binding protein; TAK1—transforming growth factor β-activated kinase
    1; TBK1—TANK-binding kinase 1; TIR—Toll/IL-1 receptor domain; TIRAP—TIR domain
    containing adaptor protein; TNF-α—tumor necrosis factor-α; TLR4 —Toll-like receptor
    4; TRAF—TNF-receptor associated factor; TRAM—TRIF-related adaptor molecule; TRIF—Toll/interleukin-1-receptor
    domain-containing adaptor inducing interferon β; TRPA1—transient receptor potential
    ankyrin 1; TRPM3—transient receptor potential melastatin 3; TRPM8—transient receptor
    potential melastatin 8; TRPV1—transient receptor potential cation channel subfamily
    V member 1; TRPV4 - transient receptor potential vanilloid 4. Adapted from ‘TLR
    Signaling Pathway’, by BioRender.com (2022). Retrieved from https://app.biorender.com/biorender-templates
    (accessed on 15 July 2022).'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - LY96
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - FOS
  - FOSB
  - JUN
  - JUNB
  - JUND
  - TLR4
  - TIRAP
  - MAL
  - MRTFA
  - RNASE9
  - TRAF6
  - IRF6
  - MAP3K7
  - NR2C2
  - TAB2
  - TAB1
  - TAB3
  - CD14
  - NDUFA2
  - CHUK
  - IKBKB
  - IKBKG
  - IKBKE
  - TBK1
  - NFKB1
  - LBP
  - EHHADH
  - RPSA
  - TRAM1
  - TICAM2
  - TMED7-TICAM2
  - TICAM1
  - TRIM69
  - IRF3
  - TRAF3
  - CXCL10
  - CXCL11
  - CXCL12
  - CXCL13
  - CXCL14
  - CXCL9
  - PF4
  - CXCL1
  - CXCL2
  - CXCL3
  - CXCL5
  - CXCL6
  - CXCL8
  - PPBP
  - COX2
  - PTGS2
  - MTCO2P12
  - COX8A
  - CPOX
  - COX5A
  - COX5B
  - COX6C
  - COX7C
  - .na.character
  - COX4I1
  - COX4I2
  - COX6A1
  - COX6A2
  - COX6B1
  - COX6B2
  - COX7A1
  - COX7A2
  - COX7B
  - COX7B2
  - COX8C
  - NOS2
  - ISYNA1
  - IRF7
  - TRPA1
  - TRPV1
  - CALCA
  - S100A12
  - IFNK
  - IFNW1
  - IFNA1
  - IFNA2
  - IFNA4
  - IFNA5
  - IFNA6
  - IFNA7
  - IFNA8
  - IFNA10
  - IFNA13
  - IFNA14
  - IFNA16
  - IFNA17
  - IFNA21
  - IFNB1
  - TRPV4
  - TRPM3
  - CASP1
  - CASP2
  - CASP4
  - CASP5
  - CASP6
  - CASP8
  - CASP9
  - CASP10
  - CASP12
  - CASP14
  - CASP3
  - CASP7
  - NLRP3
  - IGKV3D-15
---
